|
WBP11P1 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.83118000000038E-05 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03239999999605E-05 |
| Normal-vs-Stage2 |
3.422100E-02 |
| Normal-vs-Stage3 |
3.9112999999924E-06 |
| Normal-vs-Stage4 |
1.59739999999742E-05 |
| Stage1-vs-Stage2 |
1.131600E-01 |
| Stage1-vs-Stage3 |
3.791200E-01 |
| Stage1-vs-Stage4 |
3.920800E-01 |
| Stage2-vs-Stage3 |
5.150200E-02 |
| Stage2-vs-Stage4 |
4.929600E-02 |
| Stage3-vs-Stage4 |
8.708000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52036999999661E-05 |
| Normal-vs-AfricanAmerican |
3.015100E-03 |
| Normal-vs-Asian |
1.006190E-02 |
| Caucasian-vs-AfricanAmerican |
4.625800E-01 |
| Caucasian-vs-Asian |
8.150300E-02 |
| AfricanAmerican-vs-Asian |
6.184800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77610999999578E-05 |
| Normal-vs-Female |
2.36699999999201E-05 |
| Male-vs-Female |
5.013000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.75110000000456E-05 |
| Normal-vs-Age(41-60Yrs) |
3.98040000000321E-05 |
| Normal-vs-Age(61-80Yrs) |
9.69979999999593E-05 |
| Normal-vs-Age(81-100Yrs) |
1.63533999999466E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.140400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.847200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.215820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.562800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.187600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.119760E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.310600E-01 |
| Classical-VS-Follicular |
1.449190E-01 |
| Classical-VS-Other |
6.130400E-02 |
| Classical-VS-Normal |
1.174220E-04 |
| Tall-VS-Follicular |
4.972200E-01 |
| Tall-VS-Other |
6.903800E-02 |
| Tall-VS-Normal |
8.972800E-04 |
| Follicular-VS-Other |
1.674610E-01 |
| Follicular-VS-Normal |
1.80029999999887E-05 |
| Other-VS-Normal |
3.799300E-03 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.47340000000462E-05 |
| Normal-vs-N1 |
4.42509999754037E-08 |
| N0-vs-N1 |
3.157700E-03 |
|
|
